CUMULUS ONCOLOGY
Cumulus Oncology develops anti-cancer therapies for clinical settings in areas of high unmet need. We target key pathways to improve the efficacy and outcomes of current and experimental therapies. Cumulus has the backing of a successful entrepreneur in the oncology field and is led by a team of senior professionals and industry partners from across the drug discovery and development sector. Together, we offer a wealth of experience and deep insights into optimum approaches for improved cancer patient outcomes.
CUMULUS ONCOLOGY
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Lothian, Maryland, United States
Country:
United States
Website Url:
http://www.cumulusoncology.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4.1 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Organization Schema
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
GenEdit
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
ROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Eos Advisory
Eos Advisory investment in Venture Round - Cumulus Oncology
Scottish Enterprise
Scottish Enterprise investment in Venture Round - Cumulus Oncology
Key Employee Changes
Date | New article |
---|---|
2021-11-30 | Cumulus Oncology appoints its first chief business officer |
Official Site Inspections
http://www.cumulusoncology.com Semrush global rank: 6.76 M Semrush visits lastest month: 814
- Host name: olympus-lon.cloudhosting.uk
- IP address: 185.199.220.69
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Cumulus Oncology"
Cumulus Oncology - Crunchbase Investor Profile
Contact Email [email protected]; Cumulus Oncology develops anti-cancer therapies for clinical settings in areas of high unmet need. We …See details»
cumulusoncology.com Reviews: Is this site a scam or legit?
Organization Domains By Proxy, LLC ... In the context of cumulusoncology.com, our investigation continues working to pinpoint the specific category, but we welcome your insights in the …See details»
Cumulus Oncology - Company Profile & Staff Directory - ContactOut
Cumulus Oncology is developing anti-cancer therapies for clinical settings in areas of high unmet need, with the aim of developing improved outcomes for cancer patients. Cumulus has the …See details»
Cumulus Oncology - PitchBook
Cumulus Oncology General Information Description. Developer of novel therapies designed for treating cancers. The company's lead candidate is an oral, selective, and preclinical Chk1 …See details»
Position: Chief Financial O cer - cumulusoncology.com
• Strong interpersonal skills; ability to communicate across all levels of the organization as well as externally with investors and other stakeholders. • Strong problem solving and creative skills …See details»
Cumulus Oncology raises £9m in seed Ëšnancing
For more information, please visit: www.cumulusoncology.com Press Release 08 January 2024: Cumulus Oncology raises £9m in seed Ëšnancing . Press Release 08 January 2024: Cumulus …See details»
Cumulus Oncology - VentureRadar
Website: https://www.cumulusoncology.com/ Cumulus Oncology is developing anti-cancer therapies for clinical settings in areas of high unmet need, with the aim of ...See details»
Cumulus Oncology | VentureRadar
Website: https://www.cumulusoncology.com/ Revolutionizes oncology drug development by curating promising assets, leveraging seed capital, and forming biotech spin ...See details»
Cumulus Oncology: Drug pipelines, Patents, Clinical trials - Synapse
Jun 30, 2023 Explore Cumulus Oncology with its drug pipeline, therapeutic area, technology platform, .See details»
LDC and Cumulus Oncology Announce Collaboration - Lead …
For more information, please visit: www.cumulusoncology.com. About LDC Lead Discovery Center GmbH (LDC) was established in 2008 by the technology transfer organization Max …See details»
Cumulus Oncology Company Information - Funding, Investors, …
Https://cumulusoncology.com. Oncology drug discovery platform. GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY. OR DOWNLOAD OUR DATABASE OF …See details»
LDC and Cumulus Oncology announce collaboration - Yahoo …
Mar 22, 2021 LDC and Cumulus Oncology announce collaboration Dortmund, Germany, and Edinburgh, Scotland, March 22nd, 2021. The Lead Discovery Center GmbH (LDC) and …See details»
GIO Therapeutics AG – Swiss Biotech
[email protected]; Xavier Leroy; Location. Lichtstrasse 35, 4056 Basel, Switzerland. Get Directions Additional address info. ... Basel; Facts & figures. Type of organization. Private …See details»
Research programme: anti-cancer therapeutics - Cumulus …
If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with username/password or try to …See details»
Cumulus Oncology - VentureRadar
"Cumulus Oncology is developing anti-cancer therapies for clinical settings in areas of high unmet need, with the aim of developing improved outcomes for cancer patients.See details»
Privacy policy - cumulusoncology.com
Collect from users of our website hËœps://cumulusoncology.com. This Policy applies to use of any and all Data collected by Cumulus Oncology through users’ interactions with the website. This …See details»
LDC and Cumulus Oncology announce collaboration
Mar 22, 2021 Lead Discovery Center GmbH (LDC) was established in 2008 by the technology transfer organization Max Planck Innovation, as a novel approach to capitalize on the potential …See details»
230717 Cumulus Oncology LeadXpro Collaboration v1
For more information, please visit: www.cumulusoncology.com About GPCRs GPCRs, the largest human membrane protein family, play a pivotal role in drug development. With accessible …See details»
New Collaborative EËœorËš in Cancer Drug Discovery
For more information, please visit: www.cumulusoncology.com Press Release 08 April 2024: New Collaborative EËœorËš in Cancer Drug Discovery. Title: 240408-UEF_v1.1 Created Date:See details»